IL15 and glioma: After 17 days from glioma transplantation, the treatment with rAAV2-IL-15-infected microglia reduced the number of Arg1+ M/MΦ cells infiltrated in the tumor (a marker of pro-tumoral/anti-inflammatory M/MΦ phenotype (28), (Figure 4A).